Search company, investor...

Compare Stage I Diagnostics vs Upromise

Customers evaluate the quality of Stage I Diagnostics's products using the following success metrics.

Overview

Stage I Diagnostics is based in United States

Stage I Diagnostics is a cancer biotechnology company focused on providing early stage diagnosis provided by new biomarkers deployed through In-Vitro Diagnostics (IVD). The company's initial focus is the early diagnosis of ovarian cancer. Stage I's core competency is the process of converting newly discovered genes into commercial products which impact clinical decisions. The company's approach is to determine what characteristics new biomarkers should have to achieve the best diagnostic results in targeted diseases and then to discover what genes exist that fit those characteristics. This process has led us to not only discover and patent numerous genes associated with various types of cancer but also clone 4 new genes.

Upromise

Upromise is 24 yrs old and is based in United States.

Upromise's mission is to help families realize the dream of college. The Upromise Services division includes our popular Rewards Service, which allows families to automatically save money for college while making everyday purchases. Upromise also makes it easy for families to invest in tax-advantaged college savings plans and to use contributions to pay off student loans. The 529 college savings plans are offered through Upromise Investments, Inc. (member NASD/SIPC). On June 1st, 2020, Upromise was acquired by Prodege. Terms of the transaction were not disclosed.

Founded Year